SURGICAL SPECIALTIES UK HOLDINGS LIMITED
Get an alert when SURGICAL SPECIALTIES UK HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-04 (in 6mo)
Last made up 2025-10-21
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£352M
+392.6% vs 2023
Employees
0
Average over period
Profit before tax
—
Period ending 2024-12-31
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | £1,000 | — | |
| Profit before tax | -£9,878,000 | — | |
| Net profit | -£9,878,000 | — | |
| Cash | — | — | |
| Total assets less current liabilities | £71,496,000 | £352,224,000 | |
| Net assets | £71,496,000 | £352,224,000 | |
| Equity | £71,496,000 | £352,224,000 | |
| Average employees | 0 | 0 | |
| Wages | — | — | |
| Directors' remuneration | £0 | £0 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
+392.6%
£71,496,000 £352,224,000
-
Employees
—
Not reported
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | 0.0% | — | |
| Current ratio | -1.00x | — | |
| Interest cover | 0.00x | — |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future.”
Group structure
- SURGICAL SPECIALTIES UK HOLDINGS LIMITED · parent
- Pearsalls Limited 100%
- Corza Treasury 1 100%
- Corza Treasury 2 100%
- Corza Treasury 3 100%
- Corza Treasury 4 100%
- Pearsalls IP Limited 100%
- Corza Medical S.A.S. 100%
- Corza Medical GmbH 100%
- Corza Medical, S.L.U. 100%
- Corza Medical Sp. Z.o.o. 100%
- Corza Medical S.r.l. 100%
- Corza Medical BV 100%
- Surgical Specialties Germany GmbH 100%
- Corza Medical GmbH 100%
- Corza Medical GmbH 100%
- GTCR (Topaz) AcquisitionCo AS 100%
- Corza Medical, S.L.U., Sucursal em Portugal 100%
- Topaz Investment AS 100%
- Corza Medical Distribution GmbH Austria Branch 100%
- FSSB Chirurgische Nadeln GmbH 100%
- F&B GmbH 100%
- FSSB Chirurgische Nadein GmbH Zweigniederlassung Pößneck 100%
Significant events
- “During 2022, the Company paid interim dividends of £9.9 million based on unaudited financial information... Upon review of the results for the entire 2022 year, the full amount of interim dividends of £9.9 million were recalled in 2023 due to insufficient distributable reserves...”
- “On 9 January 2024, the Company acquired 100 Ordinary shares with a nominal value of £0.01 each for a total consideration of £280,728,000 from Pearsalls Limited.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 21 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ABAIR, Jason Christian | Director | 2025-03-31 | Sep 1973 | American |
| BURRIDGE, Rebecca Louise | Director | 2021-02-10 | Jun 1983 | British |
| CHAVES, Derek | Director | 2025-03-31 | Apr 1977 | American |
| LUCIER, Gregory Thomas | Director | 2025-03-31 | May 1964 | American |
Show 21 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BANKS, James Reginald | Secretary | 2004-10-21 | 2006-03-23 |
| DENT, Jay | Secretary | 2009-02-25 | 2014-07-29 |
| NESKE, Tammy | Secretary | 2013-10-08 | 2014-12-31 |
| PHINNEY, David | Secretary | 2006-03-23 | 2009-02-25 |
| SUTHERBY, Daniel Joseph | Secretary | 2014-12-31 | 2021-02-10 |
| ADLOFF, Richard | Director | 2004-10-21 | 2006-03-23 |
| BAILEY, Kenneth Thomas | Director | 2006-03-23 | 2013-10-08 |
| BANKS, James Reginald | Director | 2004-10-21 | 2006-03-23 |
| BARR, John | Director | 2014-12-31 | 2017-08-23 |
| BURMEISTER IV, Henry Augustus | Director | 2023-06-05 | 2024-07-30 |
| DAU, Nathan Minh, Mr. | Director | 2020-11-27 | 2021-02-10 |
| DENT, Jay | Director | 2009-02-25 | 2013-10-08 |
| DIAZ, Victor Manuel, Chief Operating Officer | Director | 2017-10-03 | 2021-10-06 |
| HUDSON, Michael Joseph | Director | 2004-10-21 | 2006-03-23 |
| LYON, Douglas Lawson | Director | 2004-10-21 | 2006-03-23 |
| NESKE, Tammy | Director | 2013-10-08 | 2014-12-31 |
| PHINNEY, David | Director | 2006-03-23 | 2009-02-25 |
| SUTHERBY, Daniel Joseph | Director | 2019-04-16 | 2021-02-10 |
| TESTA, Thomas | Director | 2024-07-30 | 2024-12-31 |
| TESTA, Thomas Benjamin | Director | 2021-02-10 | 2023-06-05 |
| WANG, Lawrence Allen, Mr. | Director | 2019-04-16 | 2020-11-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Surgical Specialties Corporation Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 130 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-17 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2026-01-08 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-10-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-21 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-09-24 | AA | accounts | Accounts with accounts type full | |
| 2025-04-23 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-04-16 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-15 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-15 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-15 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-20 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-30 | RP04TM01 | officers | Second filing of director termination with name | |
| 2024-09-30 | AA | accounts | Accounts with accounts type full | |
| 2024-09-11 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2024-08-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-12 | SH01 | capital | Capital allotment shares | |
| 2024-03-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-03-02 | DISS40 | gazette | Gazette filings brought up to date | |
| 2024-01-09 | GAZ1 | gazette | Gazette notice compulsory |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 1
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.